Advancement of pipeline drugs, surge in chemotherapy and increase in use of broad spectrum antibiotics supporting growth of invasive fungal infection market

Date: 1 February 2020

According to a research report published by Azoth Analytics in December 2019, the Global Invasive Fungal Infection Market was valued at USD 6103.55 million in the year 2018. Primarily, the rise in population suffering from HIV/AIDS, discovery and advancement of pipeline drugs backed with facilities provided by hospitals in intensive care units for those who have undergone surgery, surge in chemotherapy and increase in use of broad spectrum antibiotics followed by global economic growth is going to accelerate the invasive fungal infection market. 

Additionally, introduction of advanced medicines is already proven to be constructive as it directly improves the health of a immuno-compromised patient and enhances the life expectancy of a patient coupled with presence of various major economies including United States, Canada, Germany, France, Japan, China where the population is aging and undergoing chemotherapy among young population is growing. Supported by escalating investment by various leading Invasive Fungal Infection manufacturers, the Global Invasive Fungal Infection market is likely to witness immense growth during the forecast period.

Global Invasive Fungal Infection market will be majorly driven by growing population with invasive devices such as central nervous catheters or pacemakers, extremes of ages, neonates and the elderly with less immunity with presence of increasing diseases and developing healthcare expenditure in various countries across the world. Prevalence of various fungal diseases including Candidaemia and Cryptococcal Meningitis  due to lack of awareness about Intensive Unit Care after undergoing solid organ transplantation, supported by enhanced focus of companies to provide effective products and creating awareness among people about those advanced products and procedures through workshops and by taking various initiatives with rising investment by various major Invasive Antifungal manufacturers which are focusing on expanding their footprint across the world and bringing effective drugs such as CRESEMBA in the market, will be accelerating the Invasive Fungal Infection market growth globally during the coming years.

Cryptococcal Meningitis and Invasive Candidiasis, under their respective segment, are estimated to experience the highest market share largely because of escalating use of systemic corticosteroids which decrease the immunity in a patient already affected with diseases such as malignancy coupled with rising use of broad-spectrum antibiotics. These factors will be driving a notable growth in the market for Invasive Fungal Infection during the coming years. 

The Azoth Analytics research report titled Global Invasive Fungal Infection (IFI) Market (2020Edition) - Market Insight, Competition and Forecast (2019-2024)  has analysed and segmented the Invasive Fungal Infection Market by Value (USD Million). The report has analysed the Invasive Fungal Infection Market By Diseases (Candidemia and invasive Candidiasis, Intra-abdominal candidiasis (Candida Peritonitis), Cryptococcal Meningitis, Histoplasmosis Disseminated, Histoplasmosis Acute Pulmonary, Invasive aspergillosis, Invasive Rhinosinusitis, Mucormycosis, Pneumocystis Pneumonia, Others). The Global Invasive Fungal Infection Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (USA, Canada, Germany, France, United Kingdom, Spain, China, South Korea, Japan, India) for the forecast period of 2019-2024.